281 related articles for article (PubMed ID: 29975360)
21. Testing systems for assessment of negative symptoms in schizophrenia.
Fenton WS; McGlashan TH
Arch Gen Psychiatry; 1992 Mar; 49(3):179-84. PubMed ID: 1567273
[TBL] [Abstract][Full Text] [Related]
22. A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.
Strauss GP; Gold JM
Schizophr Bull; 2016 Nov; 42(6):1384-1394. PubMed ID: 27174556
[TBL] [Abstract][Full Text] [Related]
23. Issues in selection of instruments to measure negative symptoms.
Daniel DG
Schizophr Res; 2013 Nov; 150(2-3):343-5. PubMed ID: 23899996
[TBL] [Abstract][Full Text] [Related]
24. An Assessment of Five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used Symptoms Rating Scales in Schizophrenia and Comparison to Newer Scales (CAINS, BNSS).
Kumari S; Malik M; Florival C; Manalai P; Sonje S
J Addict Res Ther; 2017; 8(3):. PubMed ID: 29430333
[TBL] [Abstract][Full Text] [Related]
25. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.
Schooler NR
Acta Psychiatr Scand Suppl; 1994; 380():21-6. PubMed ID: 7914043
[TBL] [Abstract][Full Text] [Related]
26. Validation of the Brief Negative Symptom Scale and its association with functioning.
Ang MS; Rekhi G; Lee J
Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
[TBL] [Abstract][Full Text] [Related]
27. The Swedish version of the Motivation and Pleasure Scale self-report (MAP-SR): psychometric properties in patients with schizophrenia or depression.
Cernvall M; Bengtsson J; Bodén R
Nord J Psychiatry; 2024 May; 78(4):339-346. PubMed ID: 38436927
[TBL] [Abstract][Full Text] [Related]
28. A new rating scale for negative symptoms: the Motor-Affective-Social Scale.
Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L
Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021
[TBL] [Abstract][Full Text] [Related]
29. Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS).
Goetz RR; Corcoran C; Yale S; Stanford AD; Kimhy D; Amador X; Malaspina D
Schizophr Res; 2007 Jul; 93(1-3):169-77. PubMed ID: 17433629
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia.
Rekhi G; Alphs L; Ang MS; Lee J
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1433-1441. PubMed ID: 31761524
[TBL] [Abstract][Full Text] [Related]
31. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
[TBL] [Abstract][Full Text] [Related]
32. A randomized pilot study of MOtiVation and Enhancement (MOVE) Training for negative symptoms in schizophrenia.
Velligan DI; Roberts D; Mintz J; Maples N; Li X; Medellin E; Brown M
Schizophr Res; 2015 Jul; 165(2-3):175-80. PubMed ID: 25937461
[TBL] [Abstract][Full Text] [Related]
33. Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.
Park SG; Llerena K; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
Schizophr Res; 2012 Mar; 135(1-3):139-43. PubMed ID: 22265640
[TBL] [Abstract][Full Text] [Related]
34. Anticipation and experience of emotions in patients with schizophrenia and negative symptoms. An experimental study in a social context.
Engel M; Fritzsche A; Lincoln TM
Schizophr Res; 2016 Jan; 170(1):191-7. PubMed ID: 26673972
[TBL] [Abstract][Full Text] [Related]
35. [Insight in schizophrenia: assessment of 31 patients with different scales].
Travers D; Levoyer D; Millet B
Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
[TBL] [Abstract][Full Text] [Related]
36. Spanish Validation of the MAP-SR: Two Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia.
García-Portilla MP; García-Álvarez L; de la Fuente-Tomás L; Dal Santo F; Velasco A; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Bobes-Bascarán MT; Sáiz PA; Bobes J
Psicothema; 2021 Aug; 33(3):473-480. PubMed ID: 34297678
[TBL] [Abstract][Full Text] [Related]
37. Relations among clinical scales in schizophrenia.
Gur RE; Mozley PD; Resnick SM; Levick S; Erwin R; Saykin AJ; Gur RC
Am J Psychiatry; 1991 Apr; 148(4):472-8. PubMed ID: 2006693
[TBL] [Abstract][Full Text] [Related]
38. The CAINS: theoretical and practical advances in the assessment of negative symptoms in schizophrenia.
Barch DM
Am J Psychiatry; 2013 Feb; 170(2):133-5. PubMed ID: 23377630
[No Abstract] [Full Text] [Related]
39. Self-assessment of negative symptoms - Critical appraisal of the motivation and pleasure - Self-report's (MAP-SR) validity and reliability.
Richter J; Hesse K; Eberle MC; Eckstein KN; Zimmermann L; Schreiber L; Burmeister CP; Wildgruber D; Klingberg S
Compr Psychiatry; 2019 Jan; 88():22-28. PubMed ID: 30466014
[TBL] [Abstract][Full Text] [Related]
40. [Relationship between insight and self-reported quality of life among shizophrenic patients].
Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
